Krystal Biotech Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Sep '25 Sep 30, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020
Cash & Equivalents	392.6	344.87	358.33	161.9	341.25	268.27
Short-Term Investments	338.47	252.65	173.85	217.27	96.85	2.99
Cash & Short-Term Investments	731.07	597.52	532.18	379.17	438.1	271.26
Cash Growth	24.26%	12.28%	40.35%	-13.45%	61.50%	40.05%
Receivables	129.63	104.75	42.04	-	-	-
Inventory	37.63	26.51	6.99	-	-	-
Prepaid Expenses	27.32	13.27	6.71	4.61	4.17	3.8
Total Current Assets	925.65	742.05	587.91	383.78	442.27	275.06
Property, Plant & Equipment	156.32	161.45	168.23	169.73	119.58	34.17
Long-Term Investments	133.11	152.11	61.95	4.62	64.37	-
Other Long-Term Assets	0.33	0.23	0.26	0.32	0.07	1.61
Total Assets	1,240	1,056	818.36	558.45	626.3	310.84
Accounts Payable	2.1	4.99	4.13	3.98	8.4	2.11
Accrued Expenses	74.08	52.78	18.15	11.54	6.52	3.99
Current Portion of Leases	1.7	1.22	1.47	1.56	1.04	0.64
Current Income Taxes Payable	9.54	4.29	1.96	0.04	0.08	0.04
Other Current Liabilities	3.85	38.73	7.38	11.72	9.69	8.68
Total Current Liabilities	91.27	102	33.09	28.85	25.74	15.45
Long-Term Leases	7.81	6.04	6.62	7.37	6.98	3.31
Other Long-Term Liabilities	3.14	1.42	-	-	-	-
Total Liabilities	102.22	109.46	39.71	36.22	32.72	18.76
Additional Paid-In Capital	1,164	1,127	1,048	803.72	734.52	363.29
Retained Earnings	-27.24	-180.67	-269.83	-280.76	-140.78	-71.21
Comprehensive Income & Other	1.1	-0.19	0.64	-0.73	-0.16	0.01
Total Common Equity	1,138	946.38	778.64	522.23	593.58	292.08
Shareholders' Equity	1,138	946.38	778.64	522.23	593.58	292.08
Total Liabilities & Equity	1,240	1,056	818.36	558.45	626.3	310.84
Total Debt	9.51	7.26	8.09	8.93	8.02	3.95
Net Cash (Debt)	854.67	742.37	586.04	374.86	494.44	267.32
Net Cash Growth	24.45%	26.68%	56.34%	-24.19%	84.97%	40.38%
Net Cash Per Share	28.62	24.96	21.12	14.70	22.28	14.23
Filing Date Shares Outstanding	29	28.81	28.29	25.76	25.21	22.19
Total Common Shares Outstanding	28.98	28.79	28.24	25.76	25.21	19.71
Working Capital	834.38	640.05	554.82	354.93	416.53	259.61
Book Value Per Share	39.26	32.87	27.58	20.27	23.55	14.82
Tangible Book Value	1,138	946.38	778.64	522.23	593.58	292.08
Tangible Book Value Per Share	39.26	32.87	27.58	20.27	23.55	14.82
Buildings	109.24	111.44	111.18	-	-	-
Machinery	37.79	34.19	30.49	12.93	6.51	5.58
Construction In Progress	3.51	5.78	7.29	131.33	104.34	23.03
Leasehold Improvements	27.51	25.67	25.07	24.22	5.72	4.63

Source: S&P Global Market Intelligence. Standard template. Financial Sources.